LON:BMK

Benchmark Share Forecast, Price & News

GBX 46.66

-0.84 (-1.76%)

(As of 07/1/2022 02:35 PM ET)

Add

Compare

Today's Range: 46.67
▼
46.67
50-Day Range: 40
▼
54
52-Week Range: 39
▼
65.90

Volume: 31 shs
Average Volume: 566,557 shs
Market Capitalization: £328.50 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Benchmark Stock Forecast (MarketRank)

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
£2.92 M Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.39 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Benchmark.

0.0 Short Interest

Short Interest
There is no current short interest data available for BMK.

0.0 Dividend Strength

Dividend Yield
Benchmark does not currently pay a dividend.
Dividend Growth
Benchmark does not have a long track record of dividend growth.

0.0 Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BMK.

1.1 News and Social Media Coverage

News Sentiment
Benchmark has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Benchmark insiders have bought more of their company's stock than they have sold. Specifically, they have bought £29,166.36 in company stock and sold GBX 0 in company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Benchmark is -17.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Benchmark is -17.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Due to a projected decrease in earnings for Benchmark, their PEG ratio cannot be calculated.
Price to Book Value per Share Ratio
Benchmark has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

30 days | 90 days | 365 days | Advanced Chart

Receive BMK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Benchmark and its competitors with MarketBeat's FREE daily newsletter.

About Benchmark (LON:BMK)

Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge that supports the development of food and farming industries in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers salmon breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products to the aquaculture market. Benchmark Holdings plc was founded in 2000 and is based in Sheffield, the United Kingdom.

June 1, 2022 | ca.proactiveinvestors.com

Benchmark Holdings converts Norway debt to green loan after meeting ESG criteria

May 18, 2022 | proactiveinvestors.com.au

Benchmark Holdings shares boosted by 'excellent' first half

May 18, 2022 | ca.proactiveinvestors.com

Benchmark Holdings shares boosted by “excellent” first half

April 30, 2022 | finanznachrichten.de

Landesbank Baden-Württemberg - Pre-stabilisation Period Announcement

March 3, 2022 | finance.yahoo.com

Quite a few insiders invested in Benchmark Holdings plc (LON:BMK) last year which is positive news for shareholders

February 26, 2022 | uk.finance.yahoo.com

Benchmark Holdings plc (BMK.L)

December 3, 2021 | finance.yahoo.com

Benchmark Holdings plc (LON:BMK) Just Released Its Yearly Earnings: Here's What Analysts Think

December 1, 2021 | markets.businessinsider.com

Benchmark Hlgs PLC : PCA Dealing

November 30, 2021 | markets.businessinsider.com

Benchmark Hlgs PLC : Q4 Results

November 24, 2021 | au.finance.yahoo.com

The Best Samsung Galaxy Tablet Black Friday Deals (2021): Top Galaxy Tab A7, S7 & More Tablet Deals Monitored by The Consumer Post

September 1, 2021 | finance.yahoo.com

Analysts Expect Breakeven For Benchmark Holdings plc (LON:BMK) Before Long

August 20, 2021 | barrons.com

Benchmark Holdings PLC

August 17, 2021 | benzinga.com

AquaManager Partners With Leading Tilapia Genetics Company Spring Genetics

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:BMK
CUSIP: N/A
CIK: N/A
Web: www.benchmarkplc.com
Phone: +44-114-2409935
Fax: N/A
Employees: 796
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 34.57
P/E Growth: -34.89
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 42.29
Current Ratio: 2.54
Quick Ratio: 1.70

Sales & Book Value

Annual Sales: £144.84 million
Price / Sales: 2.27
Cash Flow: GBX 6.35 per share
Price / Cash Flow: 7.35
Book Value: GBX 41.70 per share
Price / Book: 1.12

Miscellaneous

Outstanding Shares: 703,961,000
Free Float: N/A
Market Cap: £328.50 million
Optionable: Not Optionable
Beta: N/A

Benchmark Frequently Asked Questions

How has Benchmark's stock performed in 2022?: Benchmark's stock was trading at GBX 57 at the beginning of the year. Since then, BMK shares have decreased by 18.1% and is now trading at GBX 46.67.
View the best growth stocks for 2022 here.
Who are Benchmark's key executives?: Benchmark's management team includes the following people:
Mr. Trond Williksen, CEO & Director (Age 59, Pay $817.52k)
Ms. Septima Maguire, CFO & Director
Ms. Ruth Layton, Co-Founder & Head of Benchmark Sustainability Science
Mr. Neil Robertson, Head of Operations
Ms. Ivonne Maria Gloria Cantu, Director of Investor Relations & Corp. Devel. (Age 53)
Ms. Jennifer Haddouk, Company Sec. & Group Legal Counsel
Ms. Corina Holmes, Group Head of People
Mr. Roland James Bonney, Group Lead of Key Account Management (Age 58)
Mr. David Babington, Managing Director of Improve International
Mr. John Marshall, Head of Animal Health
Who are some of Benchmark's key competitors?: Some companies that are related to Benchmark include Hydropothecary (THCX), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Amryt Pharma (AMYT), HLS Therapeutics (HLS), OrganiGram (OGI), Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), Leaf Mobile (LEAF), Medexus Pharmaceuticals (MDP), HEXO (HEXO), BioSyent (RX), Green Organic Dutchman (TGOD) and Delta 9 Cannabis (NINE).
View all of BMK's competitors.
What other stocks do shareholders of Benchmark own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Benchmark investors own include Indivior (INDV), Allena Pharmaceuticals (ALNA), (RED), Ampliphi Biosciences (APHB), Clinigen Group (CLIN), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), American Campus Communities (ACC), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX).

What is Benchmark's stock symbol?: Benchmark trades on the London Stock Exchange (LON) under the ticker symbol "BMK."
How do I buy shares of Benchmark?: Shares of BMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Benchmark's stock price today?: One share of BMK stock can currently be purchased for approximately GBX 46.67.
How much money does Benchmark make?: Benchmark (LON:BMK) has a market capitalization of £328.50 million and generates £144.84 million in revenue each year.
How many employees does Benchmark have?: Benchmark employs 796 workers across the globe.
How can I contact Benchmark?: Benchmark's mailing address is Benchmark House, 8 Smithy Wood Drive, SHEFFIELD, S35 1QN, United Kingdom. The official website for Benchmark is www.benchmarkplc.com. The company can be reached via phone at +44-114-2409935.

This page (LON:BMK) was last updated on 7/1/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources